Your Local News

Ramping up its effort to focus on biopharmaceuticals, Bristol -Myers Squibb will pay $16.00 per share, or $2.4 billion, for Medarex, a Princeton, N.J.-based biotech firm that is one of the few companies left on the market with robust …

December 22, 2009 (FinancialWire) — The board of Bristol -Myers Squibb Company (NYSE: BMY) has declared a 3.2 percent increase in the company’s quarterly dividend, beginning in the first quarter of 2010. The dividend increase will result …

Bristol -Myers Squibb Co. Announces Dividend Increase. Bristol -Myers Squibb News · Pharma Industry News · Bristol -Myers Squibb Co. Announces Dividend Increase Reuters Key Development – 1 hour ago. 15 reads; Feed: News for Bristol Myers …

Drugmaker Bristol -Myers Squibb Co. said Monday it raised its quarterly dividend by a penny, to 32 cents from 31 cents.

NEW YORK–(BUSINESS WIRE)–The Board of Directors of Bristol -Myers Squibb Company (NYSE: BMY) today declared a 3.2 percent increase in the company’s quarterly dividend, beginning in the first quarter of 2010. …

Bristol -Myers Squibb (NYSE: BMY) has already seen 967000 shares trade hands at 8:37 AM EST but the stock is likely to get to a return to normalcy in stock trading again as it is now past the December options expiration where it had over …

Bristol -Myers Squibb Company (NYSE: BMY) and ZymoGenetics, Inc. (NASDAQ: ZGEN) today presented final results from a Phase 1b clinical trial of PEG-Interferon lambda administered with ribavirin in relapsed and treatment-naïve hepatitis C …

Drugmaker Bristol -Myers Squibb Co. said Friday its offer to exchange shares of baby formula maker Mead Johnson Nutrition Co. for shares of its own stock was oversubscribed.

Bristol -Myers Squibb Co. (BMY), which intends to split its 83.1% stake in the Nutritional segment to concentrate exclusively on its biopharmaceutical business,

Bristol -Myers Squibb Co. (BMY), which intends to split its 83.1% stake in the Nutritional segment to concentrate exclusively on its biopharmaceutical business, announced that it will offer 0.6313 shares of Mead Johnson Nutrition Co.